Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided interfascial block for trapezius myofascial syndrome in fibromyalgia
2022-002717-41Phase 4Active
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Aug 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine, triamcinolone and sodium chloride in chronic myofascial pain (CMP) and fibromyalgia (FM) (3 arms), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Regional trapezius pain at week 12. Started Aug 2022; status: active.
02
Drugs
bupivacainetriamcinolonesodium chloride
03
Conditions
chronic myofascial pain (CMP)fibromyalgia (FM)
Beyond the preview
Go deeper on 2022-002717-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002717-41.